Chemotherapy for Lost in the Fog
ALBANY, Calif. -- Eclipse sprint champion Lost in the Fog will undergo chemotherapy sessions in hopes of putting his cancer into remission, according to trainer Greg Gilchrist. The sessions will begin this week at the University of California-Davis Veterinary Medical Teaching Hospital, he said.
"He will have six treatments, three weeks apart," Gilchrist said. "He will leave every third week to go to UC-Davis and then come back to his stall at Golden Gate Fields."
The decision to use chemotherapy was reached Friday, Gilchrist said, after a course of medication failed to shrink the size of his tumors. Lost in the Fog underwent a series of tests, including an ultrasound scan, Thursday by the medical team at UC-Davis, headed by Dr. Gary Magdesian.
Lost in the Fox had been receiving dexamethasone, a corticosteroid, in hopes of shrinking his three tumors.
"We gave him steroids for nine or 10 days," Gilchrist said. "I was concerned we hadn't given enough time, but Dr. Magdesian said it was plenty of time if it was going to shrink the tumors."
Lost in the Fog, who remains healthy looking, could probably survive from two to five months under the current treatments, Gilchrist said. His chances of living a pain-free, relatively healthy life would be in the neighborhood of two years with successful chemotherapy Gilchrist said.
The key, said Gilchrist, was for the colt to remain pain free.
"The quality of life is good right now. We're not having any problems," said Gilchrist. "As long as the quality of life is there, the horse will be there."
He said that veterinarians told him the response of horses to the side effects of chemotherapy are not as pronounced as they can be in humans. He also said that after the first three sessions, veterinarians would assess whether to proceed with the final three.
MORE HORSE RACING HEADLINES
- Irish Surf an easy winner in Grade 3 Cougar II
- V. E. Day shows courage in Curlin Stakes win
- Dance With Fate dead after accident at Del Mar
- Untapable draws Post 7 as G1 Haskell favorite